Mount Sinai chief data officer tapped to lead genomics spinout 

Stamford, Conn-based Sema4, a genomics company spun out of Mount Sinai Health System, named Andrew Kasarskis, PhD, as its new chief data officer, according to a June 17 news release. 

Advertisement

Dr. Kasarskis joins Sema4 from New York City-based Mount Sinai, where he most recently served as executive vice president and chief data officer. He is also a genetics and genomics professor and  population health professor at the Icahn School of Medicine at Mount Sinai. 

As chief data officer of Sema4, Dr. Kasarskis will oversee the development of the company’s health intelligence platform and data science to support research, development and innovation. 

“I look forward to using my expertise in digital and life sciences to leverage existing research data and data standards, and to improve the prevention, detection and treatment of diseases in support of both providers and patients,” Dr. Kasarskis said in the news release. 

Mount Sinai spun its Genetic Testing Laboratory at the Icahn School of Medicine at Mount Sinai into Sema4 in June 2017.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Lab

Advertisement

Comments are closed.